NYU Abu Dhabi Develops Dual Cancer Molecules

Researchers at New York University Abu Dhabi have developed smart molecules that can both detect and treat cancer, offering a safer and more precise approach to care. These molecules, made from Manganese and organic components, remain inactive in healthy tissue but activate in acidic tumor environments, releasing Manganese ions that enhance MRI contrast and damage cancer cells. The technology was successfully tested in aggressive glioblastoma tumors and can cross the blood-brain barrier, enabling clear imaging and therapeutic effects for brain tumors. This innovation, led by Farah Benyettou and synthesized by Thirumurugan Prakasam, with contributions from Ali Trabolsi, introduces a new generation of MRI agents that combine diagnosis and treatment, potentially making cancer care faster, safer, and more precise, and offering a safer alternative to Gadolinium-based agents.